EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) – A Trial in Progress

Jasson Villarreal Hernandez, Javier Octavio Díaz Carbonero, Chiara Paoli iD, Paola Guglielmelli iD, Mario Tiribelli iD, Francesca Palandri iD, Jesus Maria Hernandez-Rivas iD, María Laura Fox iD, Damián Cubillas García de la Torre, Graeme Greenfield iD, Ciro Rinaldi iD, Priya Sriskandarajah iD und 17 weitere

OncoTargets and Therapy · 2026-10 · Volume 19 · 1-35

DOI: 10.2147/ott.s631781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Jasson Villarreal Hernandez und 28 weiteren Autor:innen. Beteiligte Einrichtung: Hematología Clínica, Institut Català d'Oncologia-Hospital Duran i Reynals, L'Hospitalet del Llobregat, Barcelona, Spain. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IOA-244JAK1/2 inhibitionPI3Kdeltamomelotinibmyelofibrosisresistance mechanismroginolisibruxolitinib

Autor:innen und Institutionen

  • Hematología Clínica, Institut Català d'Oncologia-Hospital Duran i Reynals, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Centro di Ricerca e Innovazione per le Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera Universitaria (AOU) Careggi of the University of Florence, Florence, Italy.
  • Division of Hematology and Bone Marrow Transplantation (BMT), Department of Medicine of the University of Udine and Azienda Sanitaria Universitaria (ASU) Friuli Centrale, Udine, Italy.
  • Dipartimento di Ematologia "Seràgnoli", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of the Azienda Ospedaliero-Universitaria (AOU) Bologna, Bologna, Italy.
  • Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Hematology and Hemotherapy Department, Vall d'Hebron University Hospital, Barcelona, Spain.

ORCID-Profile: Chiara Paoli, Paola Guglielmelli, Mario Tiribelli, Francesca Palandri, Jesus Maria Hernandez-Rivas, María Laura Fox, Graeme Greenfield, Ciro Rinaldi, Priya Sriskandarajah, Fabrizio Pane, Giuseppe Lanzarone, Daniela Cilloni, Massimo Breccia, Michael Lahn, Giusy Di Conza, Tracey C Hammett, Michael Emig, Karen M Tonge, Johanne Polasek, Alessandro Lucchesi, Armando Santoro, Alessandro Maria Vannucchi

Zitieren

APA

Villarreal Hernandez, J., Carbonero, J. O. D., Paoli, C., Guglielmelli, P., Tiribelli, M., Palandri, F., Hernandez-Rivas, J. M., Fox, M. L., García de la Torre, D. C., Greenfield, G., Rinaldi, C., Sriskandarajah, P., Harrison, C., Pane, F., Lanzarone, G., Cilloni, D., Pacilli, M., Breccia, M., Lahn, M., …, & Vannucchi, A. M. (2026). Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) – A Trial in Progress. OncoTargets and Therapy, Volume 19, 1-35. https://doi.org/10.2147/ott.s631781

Vancouver

Villarreal Hernandez J, Carbonero JOD, Paoli C, Guglielmelli P, Tiribelli M, Palandri F, et al. Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) – A Trial in Progress. OncoTargets and Therapy. 2026;Volume 19:1-35. doi:10.2147/ott.s631781

BibTeX
@article{VillarrealHernandez2026,
  author = {Villarreal Hernandez, Jasson and Carbonero, Javier Octavio Díaz and Paoli, Chiara and Guglielmelli, Paola and Tiribelli, Mario and Palandri, Francesca and Hernandez-Rivas, Jesus Maria and Fox, María Laura and García de la Torre, Damián Cubillas and Greenfield, Graeme and Rinaldi, Ciro and Sriskandarajah, Priya and Harrison, Claire and Pane, Fabrizio and Lanzarone, Giuseppe and Cilloni, Daniela and Pacilli, Matteo and Breccia, Massimo and Lahn, Michael and Di Conza, Giusy and Hammett, Tracey C and Kaur, Paramjit and Emig, Michael and Tonge, Karen M and Cantarini, Mireille and Polasek, Johanne and Lucchesi, Alessandro and Santoro, Armando and Vannucchi, Alessandro Maria},
  title = {Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) – A Trial in Progress},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--35},
  doi = {10.2147/ott.s631781}
}
Kostenlos starten →